Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02050165 · ClinicalTrials.gov registry record · NA
Snacking, Satiety &Weight: A Randomized, Controlled Trial
A NA study, sponsored by Griffin Hospital.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02050165: Completed NA study, sponsored by Griffin Hospital.
NCT02050165 is a NA study that has completed, run by Griffin Hospital. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02050165, a NA study, has completed, sponsored by Griffin Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Proposed is a parallel-design randomized controlled trial to compare the effects of consuming two types of snacks on a daily basis for a 12-week period on health outcomes, diet quality, and self-reported satiety in a group of overweight adults. The types of snacks to be studied are KIND snack bars with almonds and typical American snack foods).
Primary Outcome
Body mass index (BMI) will be calculated as weight (kg) divided by height in meters (m) squared. Waist circumference will be measured using guidelines of the National Obesity Expert Panel Report.
Interventions
- DIETARY_SUPPLEMENT KIND Bars
- DIETARY_SUPPLEMENT Typical American Snack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT02050165 record still lists
NCT02050165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which KIND Bars is the first listed.
NCT02050165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02050165 about?
NCT02050165 is a clinical study titled "Snacking, Satiety &Weight: A Randomized, Controlled Trial". Proposed is a parallel-design randomized controlled trial to compare the effects of consuming two types of snacks on a daily basis for a 12-week period on health outcomes, diet quality, and self-reported satiety in a group of overweight adults. The types of snacks to be studied are KIND snack bars w...
What is the current status of trial NCT02050165?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2012-04. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02050165?
The interventions under investigation include: KIND Bars (DIETARY_SUPPLEMENT), Typical American Snack (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02050165?
This trial is sponsored by Griffin Hospital, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02050165's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia